详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Shi, Y-K.[1,2,3] * ; Chen, G.[4] ; Wang, X.[5] ; Liu, Y.[6] ; Wu, L.[7] ; Hao, Y.[8] ; Liu, C.[9] ; Zhu, S.[10] ; Zhang, X.[11] ; Li, Y.[12] ; Liu, J.[13] ; Cao, L.[14] ; Cheng, Y.[15] ; Zhao, H.[16] ; Zhang, S.[17] ; Zang, A.[18]

; Cui, J.[19] ; Feng, J.[20] ; Liu, F.[21] ; Gu, C.[21] ;

机构： [1]Natl Canc Ctr, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China [2]Natl Clin Res Ctr Canc, Beijing, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Beijing, Peoples R China [4]Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China [5]Xuzhou Cent Hosp, Dept Med Oncol, Xuzhou, Jiangsu, Peoples R China [6]China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China [7]Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Thorac Med Dept 2, Changsha, Peoples R China [8]Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Med Oncol, Nanning, Peoples R China [9]Xinjiang Med Univ, Canc Hosp, Dept Pulm Med, Urumqi, Peoples R China [10]Xuzhou Med Coll, Affiliated Hosp, Dept Resp Med, Xuzhou, Jiangsu, Peoples R China [11]Nantong Canc Hosp, Dept Med Oncol, Nantong, Peoples R China [12]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [13]Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian, Peoples R China [14]USTC, Affiliated Hosp 1, Dept Resp Med, Hefei, Peoples R China [15]Jilin Canc Hosp, Dept Oncol, Changchun, Peoples R China [16]Anhui Univ, Hosp 2, Dept Resp & Crit Care Med, Hefei, Peoples R China [17]Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Oncol Inst, Dept Oncol, Beijing, Peoples R China [18]Hebei Univ,Affiliated Hosp,Dept Med Oncol,Baoding,Peoples R China [19]First Hosp Jilin Univ, Canc Ctr, Changchun, Peoples R China [20]Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong, Peoples R China [21]Shanghai Allist Pharmaceut Technol, Shanghai, Peoples R China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2022]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Natl Canc Ctr, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China [2]Natl Clin Res Ctr Canc, Beijing, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Furmonertinib versus gefitinib in treatment-naive EGFR mutated non-small cell lung cancer: A randomized, double-blind, multi-center, phase III study (FURLONG)

文献详情